IHE · iShares U.S. Pharmaceuticals ETF ETF

$104.68 -0.74 (-0.70%) At close · Sep 4

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Use institutional holdings through the 13F API or MCP →

Quarter:

Holders: 3

Total Value: $3,710,596

Total Shares: 37,477

Institutional Ownership Trend

16 quarters

Holder Concentration

Across 3 13F filers · Δ vs Sep 30, 2025

Top Holder

76.6%

−23.4 pts

Top 5

100.0%

0.0 pts

Top 10

100.0%

0.0 pts

HHI

6,214

Highly concentrated−3,786

Quarterly Activity

vs Sep 30, 2025

New

Increased

Decreased

Sold Out

Unchanged

Holder count: +2

Institutional value: +965.8%

Shares held: +681.1%

Top New Positions

vs Sep 30, 2025

Institution	Acquired	Value (USD)
Mega CITADEL ADVISORS LLC	28,720	$2,843,567
Large Corient Private Wealth LLC	6,561	$649,604
Small BROWN, LISLE/CUMMINGS, INC.	2,196	$217,425

Top Sold-Out Positions

vs Sep 30, 2025

Institution	Previously Held	Last Value (USD)	Open
Small Advus Financial Partners, LLC	4,798	$348,142

Filter: New 3 Increased 0 Reduced 0 Sold out 1 Unchanged 0

Showing 4 of 4

All Common Calls Puts

Compact Export CSV

Holder

Value (USD)

% of 13F

CITADEL ADVISORS LLC IHE

$2,576,240

69.43%

26,020

This filing is a combination report: the position is filed across the managers below.

Manager	Shares	Value (USD)	% of position	Discretion
Citadel Securities GP LLC	26,020	$2,576,240	100.0%	Defined

Corient Private Wealth LLC IHE

$649,604

17.51%

6,561

CITADEL ADVISORS LLC IHE

$267,327

7.20%

2,700

This filing is a combination report: the position is filed across the managers below.

Manager	Shares	Value (USD)	% of position	Discretion
Citadel Securities GP LLC	2,700	$267,327	100.0%	Defined

BROWN, LISLE/CUMMINGS, INC. IHE

$217,425

5.86%

2,196